Related Experiment Video
Updated: Dec 17, 2025

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems
Bingren Tian1, Yumei Liu1, Jiayue Liu2
1College of Chemistry and Chemical Engineering, Xinjiang University, Urumchi 830001, China.
Abstract:
Cancer has been a threat to human health, so its treatment is a huge challenge to the present medical field. One of commonly used methods is the controlled release of anticancer drug to reduce the dose for patients, increase the stability of drug treatment and minimize side effects. Cyclodextrin is a kind of cyclic oligosaccharide produced by amylase hydrolysis. Because cyclodextrin contains a cavity structure and active hydroxyl groups, it has a positive effect on the study of the controlled release of anticancer drugs. This article reviews the controlled release of current anticancer drugs based on cyclodextrins as a "flexible switch", and discusses the classification of different types of release systems, highlighting their role in cancer treatment. Moreover, the opportunities and challenges of cyclodextrin as a magic switch in the controlled release of anticancer drugs are discussed.
Related Concept Videos
Drug-Receptor Bonds
In...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drugs that Destabilize Microtubules
Drug Distribution: Tissue Binding
For...

